Cite
MLA Citation
R. Chen et al.. “BLOCKADE OF THE PD‐1 CHECKPOINT WITH ANTI–PD‐L1 ANTIBODY AVELUMAB IS SUFFICIENT FOR CLINICAL ACTIVITY IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (CHL).” Hematological oncology, vol. 35, n.d., p. 67. http://access.bl.uk/ark:/81055/vdc_100047415531.0x000037